Johnson & Johnson to Pay $700 Million to Settle Talc Investigation
January 8, 2024 — In a major development, Johnson & Johnson (J&J) has tentatively agreed to pay approximately $700 million to resolve an investigation conducted by more than 40 US states. The investigation looked into claims that J&J wrongfully marketed its talc-based baby powder without warning consumers about potential health risks. The settlement aims to avert potential lawsuits alleging that J&J concealed any links between talc and various cancers. This agreement comes after two failed attempts by J&J to impose a settlement on former users through bankruptcy courts.
The Background
J&J, headquartered in New Brunswick, New Jersey, has faced a decade-long litigation over allegations of concealing health risks associated with its talc-based powders. The company’s stock price has been impacted significantly due to the ongoing litigation and the prospect of potential future cancer suits. As part of its strategy to address the mounting legal challenges, J&J had previously offered a $9 billion settlement to resolve all current and future claims related to its baby powder.
Talc Settlement Details
The recent settlement of approximately $700 million is a significant step towards resolving the claims against J&J. The specific terms of the agreement are still being negotiated between J&J and representatives for the state attorneys general. However, both parties have reached an agreement on the approximate total amount. This settlement is separate from the lawsuits filed by the states of Mississippi and New Mexico, which are seeking higher settlements as they have already initiated litigation.
Legal Exposure and Allegations
J&J faces legal exposure beyond the claims made by the states involved in the settlement. The company is confronted with over 50,000 lawsuits alleging that its talc-based powders, including baby powder, contained asbestos and posed a cancer risk. While the majority of these claims relate to ovarian cancer, some also involve mesothelioma, a cancer associated with asbestos exposure. J&J maintains that its talc-based products do not cause cancer and that it has marketed its baby powder responsibly for more than a century.
Impact on J & J’s Stock Price
The ongoing litigation and the potential financial impact from settlements have affected J&J’s stock price. Following news of the settlement, J&J’s shares experienced a slight decline in trading. The resolution of the talc investigation and subsequent settlements may help alleviate some of the uncertainties surrounding the company, potentially leading to a positive impact on its stock price.
Various State Lawsuits and Investigation
While only Mississippi and New Mexico have filed lawsuits against J&J over the marketing of its talcum powder, a joint investigation was launched by 42 states and the District of Columbia. Attorneys general from several states, including Arizona and North Carolina, have demanded information from J&J regarding its marketing practices. The settlement agreement being negotiated does not cover the ongoing lawsuits filed by Mississippi and New Mexico, which are pursuing higher settlements as they have already initiated litigation.
Future Outlook for J&J
The settlement reached by J&J to resolve the talc investigation is a significant development in the ongoing legal challenges faced by the company. While it marks progress in addressing the allegations of concealing health risks, J&J still faces numerous lawsuits related to its talc-based powders. The outcome of these lawsuits will determine the long-term impact on the company and its reputation. J&J continues to maintain its stance that its talc-based products are safe and do not cause cancer.
Details on the Talc Settlement Amounts
Johnson & Johnson’s agreement to pay approximately $700 million to settle the talc investigation by more than 40 US states is a significant step towards resolving the legal challenges the company has faced. The settlement aims to address allegations that J&J wrongfully marketed its talc-based baby powder without warning consumers about potential health risks. While this settlement is a positive development for J&J, the company still faces numerous lawsuits related to its talc-based powders. The outcome of these lawsuits will shape the future of the company and its reputation in the healthcare industry.
Table 1: Settlement Details
| Settlement Amount | Approx. $700 million |
|---|---|
| Lawsuits Covered | Multiple states |
| Allegations | Wrongful marketing, failure to warn about health risks |
| Ongoing Lawsuits | Mississippi, New Mexico |
| Legal Exposure | Over 50,000 claims related to talc-based powders |
March 2, 2023 — An NBC News story posted on February 4, 2023 looked at the long legal battles facing Johnson & Johnson over its alleged link to ovarian cancer in women and the delay in future payouts for victims.
The plaintiffs received a partial victory by ways of a federal appeals court rejected J&J’s attempt to move more than 38,000 lawsuits to a bankruptcy court.
What’s known in the legal world as the “Texas Two-Step” was an attempt to create a subsidiary called LTL Management that would take on the massive burden of all related cancer claims against the company. As most lawyers expected, within days of J&J creating this new entity they filed for Chapter II bankruptcy.
One plaintiffs’ case was delayed for 15 months due to the weak J&J bankruptcy plan. Deborah Smith stated that the whole thing “felt like a slap in the face.”
She went on to say of J&J – “If that was someone in their family, would they drag it out like that?” “It’s almost like they’re playing a waiting game to see how many people will just die or just give up fighting.”
It was in 2003 when Smith was diagnosed with a tumor (a uterine fibroid), she underwent two surgeries and three rounds of chemotherapy which then caused her to lose her hair in clumps. She now actively wears wigs in public.
Talcum Powder lawsuit payout
Back in November 2020, Johnson & Johnson was been ordered by a New York state judge to payout $120 million in damages to a Brooklyn woman and her husband, after she blamed her cancer on asbestos exposure from using the company’s baby powder.
The original amount was $325 million but was reduced in court. It includes $15 million of compensatory damages and $105 million of punitive damages, down from an original $25 million and $300 million, respectively.
In another court victory a woman who developed ovarian cancer after years of consistent talc use on or around her genitals won a $70 million lawsuit, where $65 million of the settlement was awarded as punitive damages. According to Law360, Johnson & Johnson had callously joked in emails about talc causing ovarian cancer in women who consistently used their product and even took steps to falsify medical records to hide the connection.
Two other lawsuits similar in nature saw Johnson & Johnson losing $72 million and $55 million respectively. Both again were women citing the link between their ovarian cancer diagnosis and their usage of talcum powder.
Philip Depoian, 68, of West Hills, CA, was diagnosed with mesothelioma in 2015 claiming his exposure to asbestos over several decades while hanging out in his family’s barbershop beginning in 1948. No other exposure to asbestos could be found but the mesothelioma diagnosis was real. This opens up the talc claims now to both men and women with potentially large cash payouts from any settlements that may take place.
Possibly other cancer related diseases may be linked to talc.
The link between asbestos and various cancers has been well documented over the past 50 years. Industrial workers handling materials containing asbestos fibers have suffered greatly, acquiring serious and even terminal illnesses from lung cancer, to asbestosis and mesothelioma.
Although the talcum powder lawsuit against Johnson & Johnson typically was for ovarian cancer in women and did not include other types of cancers in both men and women, talc claimants linking colon cancer, colo-rectal cancer, uterine cancer, and even testicular cancers may be just around the corner.
It’s clear that sustained exposure to asbestos found in talcum powder can be cancerous. Now we understand that airborne talc can potentially cause lung cancer, asbestosis and mesothelioma. If these particles are inhaled there is a much wider range of possible ways a person could be exposed and suffer injuries. Everywhere today, talc can be used in plastics, ceramics, paint, paper, cosmetics, roofing, rubber and many other products.
How to File a Talcum Powder Lawsuit.
For those looking to file a talcum powder lawsuit against Johnson & Johnson, the Schmidt National Law Group has several resources available to help.
The first step is to fill out our secure intake claims form on the right side of this page, or simply call us direct at 1-800-631-5656.
If you have been diagnosed with any type of cancer that you believe could be the result of talcum powder exposure, call our law firm today. We have done our research and are well equipped to assist you and your family in this difficult time. We can help you deal with the impact that the cancer has on you and your family and will fight for your right to just compensation.
Talcum powder lawsuit update, payout settlement amounts page updated on January 8, 2024.